Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1998 Oct;10(4):291-9.
doi: 10.1016/s1043-0679(98)70030-9.

Video-assisted thoracic surgery (VATS) lobectomy: the Edinburgh experience

Affiliations

Video-assisted thoracic surgery (VATS) lobectomy: the Edinburgh experience

W S Walker. Semin Thorac Cardiovasc Surg. 1998 Oct.

Abstract

One hundred fifty video-assisted thoracic surgery (VATS) endoscopic hilar dissection lobectomy procedures are presented. Median blood loss was 65 mL and correlated with operative time (P < .0001) which averaged 144 minutes. Conversion to open thoracotomy was required in a further 20 patients (11.8%). One VATS patient (0.67%) died at 4 days from a catastrophic pulmonary embolus and 2 patients died within 30 days of surgery from pulmonary embolism and adrenal failure (overall 30-day mortality, 2%). Serious complications occurred in 3 cases: bronchopleural fistula (1) and requirement for ventilation (2). Air leakage (>4 days) occurred in 17 patients, correlated (P < .0003) with the presence of either adhesions or fissural fusion (11.3%), and resulted in prolonged hospitalization compared with patients without air leakage (11.1 vs 6.7 days; P < .0004). Open thoracotomy patients required 42% more morphine (P < .001) and 25% more nerve blocks than VATS patients (P < .001) who were 33% more likely to sleep following surgery (P < 0.01). Follow-up of 97 patients with non-small cell lung cancer (2,634 months total: mean 27) revealed 14 recurrences: 10 systemic and 4 (28.6%) within the thorax. No port site or pleural recurrences occurred. Stage analysis showed survival free of lung cancer-related death of 94% at 36 months for Stage I, 57% for Stage II, and 25% for Stage III.

PubMed Disclaimer

Similar articles

Cited by

MeSH terms

LinkOut - more resources